Organon & Co.
OGN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,835 | $3,681 | $7,097 | $7,721 |
| - Cash | $675 | $693 | $706 | $737 |
| + Debt | $8,880 | $8,931 | $9,112 | $9,364 |
| Enterprise Value | $12,040 | $11,919 | $15,503 | $16,348 |
| Revenue | $6,403 | $6,263 | $6,174 | $6,304 |
| % Growth | 2.2% | 1.4% | -2.1% | – |
| Gross Profit | $3,715 | $3,748 | $3,880 | $3,922 |
| % Margin | 58% | 59.8% | 62.8% | 62.2% |
| EBITDA | $1,604 | $1,436 | $1,756 | $1,982 |
| % Margin | 25.1% | 22.9% | 28.4% | 31.4% |
| Net Income | $864 | $1,023 | $917 | $1,351 |
| % Margin | 13.5% | 16.3% | 14.9% | 21.4% |
| EPS Diluted | 3.33 | 3.99 | 3.59 | 5.33 |
| % Growth | -16.5% | 11.1% | -32.6% | – |
| Operating Cash Flow | $939 | $799 | $858 | $2,458 |
| Capital Expenditures | -$351 | -$261 | -$427 | -$488 |
| Free Cash Flow | $588 | $538 | $431 | $1,970 |